Andere talen Adaptive Biotechnologies Corporation

Aandelen

ADPT

US00650F1093

Beurs gesloten - Nasdaq Andere beurzen 22:00:01 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,78 ^USD	+6,11%		+6,92%	-43,27%

02/04	Adaptive Biotechnologies rapporteert voorlopige omzet over Q1 en benoemt Kyle Piskel tot CFO	MT
02/04	Transcript : Adaptive Biotechnologies Corporation - Special Call

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024	17/04
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024	05/04
Adaptive Biotechnologies Corporation Announces CFO Changes	03/04
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	02/04
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue	02/04
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	02/04
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	15/02
Adaptive Biotechnologies: Q4 Earnings Snapshot	14/02
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q4 Revenue $45.8M, vs. Street Est of $48.5M	14/02
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results	14/02
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29/01
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024	29/01
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27/12
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference	27/12
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting	09/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Adaptive Biotechnologies Corporation

Aandelen

ADPT

US00650F1093

Andere talen

Filters